Immuneering Corporation (IMRX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.5600 |
| Open | 1.7300 |
| Bid | 1.6200 x 300 |
| Ask | 1.6500 x 100 |
| Day's Range | 1.6000 - 1.7300 |
| 52 Week Range | 1.3800 - 11.9200 |
| Volume | |
| Avg. Volume | 754,996 |
| Market Cap | 48.632M |
| Beta (5Y Monthly) | -0.89 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Immuneering Director Acquires 7.5% More Stock
Potential Immuneering Corporation ( NASDAQ:IMRX ) shareholders may wish to note that the Director, Peter Feinberg...
- Zacks
Immuneering (IMRX) Plummets 71% in One Week: Here's Why
Immuneering (IMRX) plunges after multiple Wall Street analysts downgraded the stock on lackluster results from an early-stage study evaluating its lead drug across advanced RAS-mutant solid tumors.
- GuruFocus.com
Immuneering Corp (IMRX) Reports Q4 and Full Year 2023 Financial Results
Key Financial Metrics and Business Updates Highlighted
© 2024 Yahoo. All rights reserved.